Gynuity Health Projects

Resources

Resources by Last Update

2011

July

Map of Misoprostol Approval

June

Map of Mifepristone Approval

List of Mifepristone Approval

Misoprostol for Treatment of Postpartum Hemorrhage

2010

November

Postpartum Hemorrhage Program Brief

Clinical Studies List

2009

December

Medical Abortion Guidebook

May

Medical Abortion Program Brief

Pregnancy Failure and Miscarriage Program Brief

March

Fever after treatment of postpartum hemorrhage

Blood Loss After Vaginal Delivery

Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials

2008

July

Annotated Bibliography - Misoprostol for Early Abortion

June

Reference List - Misoprostol for Incomplete Abortion and Miscarriage

Policy and Advocacy Activities Brief

Misoprostol for Incomplete Abortion and Miscarriage

Misoprostol for Early Abortion

Medical Abortion in the U.S.: Mifepristone Fact Sheet

Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan

Treatment of incomplete abortion and miscarriage with misoprostol

Misoprostol to treat missed abortion in the first trimester

Supervision for use of mifepristone medical abortion

Misoprostol and Teratogenicity: Reviewing the Evidence

Misoprostol for Prevention of Postpartum Hemorrhage

PAC in Action Newsletter: Special Issue on Misoprostol in the PAC Context

Relationship of Hormonal Contraception to HIV

FAQ on Hormonal Contraception and HIV

Issue Brief on Hormonal Contraception and HIV

Outlook Newsletter on Hormonal Contraception and HIV

FAQs on Fatal Infection and Medical Abortion - Technical Version

FAQs on Fatal Infection and Medical Abortion - Summary

Misoprostol for Women’s Health

Route of Misoprostol Administration

Treatment of postpartum hemorrhage with misoprostol

Prevention of postpartum hemorrhage with misoprostol

Reproductive intentions among HIV-positive women and men

Misoprostol for incomplete abortion in Tanzania

Misoprostol for incomplete abortion in Burkina Faso

Perspectives on reproductive decision-making amongst HIV-infected individuals

Misoprostol for incomplete abortion in Mozambique

Mifepristone for late first trimester abortion

Can mifepristone medical abortion be simplified?

Are two doses of misoprostol after mifepristone for early abortion better than one?

Alternatives to mifepristone for early medical abortion

Use of sequential serum hCG and sonography for medical abortion only when indicated

Misoprostol for uterine evacuation in induced abortion and pregnancy failure

Pre-eclampsia Program Brief

Materials Development Activities Brief

Social Science Research Activities Brief

Technical Assistance Activities Brief

Training and Education Activities Brief

Medical abortion: Outcomes in a family medicine setting

The Product Problem:  Pathways for Making Misoprostol Available for Postpartum Hemorrhage

Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru

Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii

Expanding Choice in Abortion Services in Armenia

Two distinct oral routes of misoprostol in mifepristone medical abortion

Integrating medical abortion into safe abortion services in South Africa

Community-based kangaroo mother care to prevent neonatal and infant mortality

Early pregnancy termination

Clostridium sordellii infection in medical abortion

Regimens of misoprostol with mifepristone for early medical abortion

Abortion and sex determination

Improving Current Therapies and Exploring New Options in Abortifacient Technology

Mifepristone medical abortion in Albania

Sublingual misoprostol after mifepristone

Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan

Sublingual misoprostol for incomplete abortion

Guidebook on Misoprostol for Treatment of Incomplete Abortion

Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2

Comparison of serum markers for thrombophilia and autoimmune disease

Knowledge, attitudes, and practice of abortion among women and doctors in Armenia

Acceptability and feasibility of medical abortion in Nepal

Annotated Bibliography - Mifepristone Medical Abortion

Home administration of misoprostol for early medical abortion in India

Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2

ICMA Third International Conference

Alternatives to Routine Follow-Up for Early Medical Abortion

High fever following postpartum administration of sublingual misoprostol

What measured blood loss tells us about postpartum bleeding

Misoprostol, Abortion, and the Law

Misoprostol as adjunct treatment for treatment of postpartum haemorrhage

Unsafe Abortion and Strategies to Reduce its Impact on Women’s Lives

Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt

Misoprostol for PPH prevention in homebirths in Pakistan

Misoprostol to augment routine active management of the third stage of labor

Ultrasound for eligibility assessment for medical abortion

Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone

Pericoital Oral Contraception with Levonorgestrel: A Systematic Review

Exploration of a new procedure for sterilization

Introduction and provision of medical abortion: A tale of two countries

Medical abortion for adolescents

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion

Review of the Literature on Patient Satisfaction with Early Medical Abortion

Oral Misoprostol for the Management of Incomplete Abortion in Ecuador

Pericoital Oral Contraception

Abortion: What is the problem?

Misoprostol for Incomplete Abortion in Guatemala

Misoprostol for the prevention and treatment of postpartum hemorrhage

Misoprostol for postpartum hemorrhage: Moving from evidence to practice